Study of Bacteria, Fungi, Virus, Rickettsiae, and Spirochetes
Curriculum Unit: 2. Classification of microbes:
Overview & Academic Context
This study module covers "Study of Bacteria, Fungi, Virus, Rickettsiae, and Spirochetes", an integral component of the Year 2 Doctor of Pharmacy (Pharm.D) curriculum under Pharmaceutical Microbiology (Classification of microbes). Designed for clinical pharmacy scholars, the syllabus emphasizes mechanistic understanding, clinical relevance, and high-yield examination competencies.
Core Study Concepts
Learning Objectives
Upon reviewing this syllabus topic, Pharm.D students are expected to demonstrate proficiency in:
- Understand the foundational etiology, classification, and clinical significance of Study of Bacteria, Fungi, Virus, Rickettsiae, and Spirochetes.
- Analyze the underlying pathophysiology and disease manifestations relevant to Classification of microbes.
- Evaluate evidence-based pharmacotherapeutic management, therapeutic drug choices, and dosage individualization.
- Identify critical patient monitoring parameters, adverse drug reactions (ADRs), and drug-drug interactions.
Unlock Complete Interactive Notes for Study of Bacteria, Fungi, Virus, Rickettsiae, and Spirochetes
Access clinical pathophysiology flowcharts, high-yield treatment algorithms, dose adjustment tables, AMBOSS-style search, interactive self-assessment quizzes, and board-exam mnemonics.
Curriculum References & Recommended Texts
Standard literature and institutional sources for Pharmaceutical Microbiology:
- [1]Pharmacy Council of India (PCI) Pharm.D Curriculum Syllabus Guidelines
- [2]Pharmaceutical Microbiology (W.B. Hugo and A.D. Russell)
- [3]Prescott's Microbiology (Willey, Sherwood, Woolverton)